Covered recipient · General Payments record
THERESA M FULLENKAMP
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2025
$674.71
- Reported across 33 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $284.40 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $40.08 | 2 |
| GlaxoSmithKline, LLC. | $36.70 | 2 |
| PFIZER INC. | $32.55 | 2 |
| Abbott Laboratories | $32.51 | 2 |
| Daiichi Sankyo Inc. | $24.63 | 1 |
| Vanda Pharmaceuticals Inc. | $24.61 | 1 |
| Lilly USA, LLC | $16.35 | 1 |
| Novo Nordisk AS | $16.33 | 1 |
| ABIOMED | $15.73 | 1 |
| Verona Pharma, Inc. | $15.37 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.87 | 1 |
| Amgen Inc. | $14.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.88 | 03/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240917513 | CMS |
| Abbott Laboratories | $15.63 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241002220 | CMS |
| ABIOMED | $15.73 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174610720 | CMS |
| Amgen Inc. | $14.67 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228849228 | CMS |
| Daiichi Sankyo Inc. | $24.63 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197101107 | CMS |
| Exact Sciences Corporation | $19.88 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235268877 | CMS |
| Exact Sciences Corporation | $20.20 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235268879 | CMS |
| GlaxoSmithKline, LLC. | $18.53 | 02/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190916375 | CMS |
| GlaxoSmithKline, LLC. | $18.17 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190462831 | CMS |
| Lilly USA, LLC | $16.35 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187298035 | CMS |
| Novo Nordisk Inc | $16.33 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189025701 | CMS |
| PFIZER INC. | $16.57 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229948737 | CMS |
| PFIZER INC. | $15.98 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230780250 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.87 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223971299 | CMS |
| Vanda Pharmaceuticals Inc. | $24.61 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233056112 | CMS |
| Verona Pharma, Inc. | $15.37 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233783446 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.